Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.9585 EUR
−13.60 M EUR
101.02 K EUR
15.07 M
About Organovo Holdings, Inc.
Sector
Industry
CEO
Keith Murphy
Website
Headquarters
San Diego
Founded
2012
FIGI
BBG003LR18C8
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange ORGANOVO HLDGS DL-,01 stocks are traded under the ticker 4OR1.
We've gathered analysts' opinions on ORGANOVO HLDGS DL-,01 future price: according to them, 4OR1 price has a max estimate of 5.04 EUR and a min estimate of 5.04 EUR. Watch 4OR1 chart and read a more detailed ORGANOVO HLDGS DL-,01 stock forecast: see what analysts think of ORGANOVO HLDGS DL-,01 and suggest that you do with its stocks.
4OR1 reached its all-time high on Feb 12, 2021 with the price of 19.0000 EUR, and its all-time low was 0.3005 EUR and was reached on Nov 15, 2024. View more price dynamics on 4OR1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ORGANOVO HLDGS DL-,01 financials in yearly and quarterly reports right on TradingView.
ORGANOVO HLDGS DL-,01 is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
4OR1 earnings for the last quarter are −0.13 EUR per share, whereas the estimation was −0.23 EUR resulting in a 46.15% surprise. The estimated earnings for the next quarter are −0.20 EUR per share. See more details about ORGANOVO HLDGS DL-,01 earnings.
ORGANOVO HLDGS DL-,01 revenue for the last quarter amounts to 26.94 K EUR, despite the estimated figure of 36.82 K EUR. In the next quarter, revenue is expected to reach 42.30 K EUR.
4OR1 net income for the last quarter is −2.29 M EUR, while the quarter before that showed −3.12 M EUR of net income which accounts for 26.67% change. Track more ORGANOVO HLDGS DL-,01 financial stats to get the full picture.
No, 4OR1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 20.00 employees. See our rating of the largest employees — is ORGANOVO HLDGS DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANOVO HLDGS DL-,01 EBITDA is −11.22 M EUR, and current EBITDA margin is −13.58 K%. See more stats in ORGANOVO HLDGS DL-,01 financial statements.
Like other stocks, 4OR1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANOVO HLDGS DL-,01 stock right from TradingView charts — choose your broker and connect to your account.